MENS (Jyong Biotech Limited) Bathi resik

Inelastic demand for the unique plant-based pharmaceuticals of Jyong Biotech Ltd (MENS) contrasts with management's focus on expanding distribution networks. The company's net operating result allows for a balance of these factors, while -0.01 reflects the latest metric value. However, reliance on third-party manufacturing creates risks that management seeks to mitigate by sourcing new reliable contractors.

MENS (Jyong Biotech) riwayat Bathi resik perusahaan saka 18.06.2025 nganti 31.10.2026

Rincian metrik keuangan lan pasar Jyong Biotech (MENS)

- rega lan prakiraan konsensus rega:

Kutipan saham Jyong Bio|MENS - Prakiraan konsensus analis

- indikator valuasi pasar bisnis:

Kapitalisasi pasar Jyong Bio|MENS - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- data kapitalisasi buku:

Nilai Akuntansi Saham Jyong Biotech|MENS - Nilai Buku Perusahaan|Koefisien Nilai Pasar marang Nilai Buku jyongbio.com|MENS - Gunggung Aset Perusahaan

- informasi babagan utang lan solvabilitas:

Utang Agregat marang Modal Jyong Biotech Ltd|MENS - Utang jangka dawa marang modal|Rasio tanggungan utang jangka cendhak marang modal Jyong Biotech Limited|MENS - Gunggung utang perusahaan|Utang-utang marang nilai buku Jyong Bio|MENS - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Jyong Biotech|Rasio likuiditas perantara jyongbio.com

- indikator pendapatan resik lan kelipatan nilai:

MENS - Penghasilan resik

Pambiji fundamental:MENS Jyong Bio

Investors are assessing the potential of Jyong Biotech Ltd (MENS) through the lens of the efficiency of its innovative developments in men's health. The daily calculation of the company's actual profit eliminates the reporting time lag, capturing daily operational dynamics and confirming the commercial sustainability of science-backed solutions, which allows this asset to be classified as a fundamentally significant biopharmaceutical tool.

Pesaing utama